Stay updated with breaking news from Inhalation Solution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EQS-Ad-hoc: Polyphor AG / Key word: Study Polyphor and EnBiotix announce dosing of first patient in a first-in-human clinical trial of inhaled murepavadin 15-Dec-2021 / 07:15 CET/CEST Release of... | December 15, 2021
Investegate announcements from Polyphor AG, Study
GuruFocus Article or News written by ACCESSWIRE and the topic is about:
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation with a purpose to provide a brighter future for patients, today...
/PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced an update on the U.S. Food and Drug Administration (FDA) review of the new drug...